Pet Allergy Treatment Drugs Market

Allergy to cats and dogs is extremely common and occurs in up to 25% of people with allergies. Cat allergies are twice as common as dog allergies. Cat allergens are produced in large amounts, particularly by male non-neutered cats. The allergens are partially under hormonal control. Cats produce a protein known as Fel d 1, which is allergenic to human beings when it is infected with bacteria or viruses. The infected protein is contained in a pet?s urine, saliva, and skin. The dead skin of pets known as dander is regularly sloughed off and replaced by new skin cells. The dander can flake off from a pet?s fur and become airborne. It can be carried on the clothing of people who have pets such as cats and dogs and then shed in public places. Therefore, pet allergens especially that of cats and dogs, are a component of house dust even in homes where cats and dogs have never lived.

Pet Allergy Treatment Drugs Market contains market size and forecasts of Pet Allergy Treatment Drugs in Global, including the following market information:

• Global Pet Allergy Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Pet Allergy Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antihistamines Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pet Allergy Treatment Drugs include Sunovion Pharmaceuticals Inc, Allergon AB, AbbVie(Allergan), HAL Allergy Group, Allergy Therapeutics, Teva Pharmaceutical, Viatris, GlaxoSmithKline and Stallergenes Greer. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Pet Allergy Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pet Allergy Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Pet Allergy Treatment Drugs Market Segment Percentages, by Type, 2021 (%)

• Antihistamines
• Decongestants
• Corticosteroid
• Others

Global Pet Allergy Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Pet Allergy Treatment Drugs Market Segment Percentages, by Application, 2021 (%)

• Dog
• Cat
• Others

Global Pet Allergy Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Pet Allergy Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Pet Allergy Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Pet Allergy Treatment Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sunovion Pharmaceuticals Inc
• Allergon AB
• AbbVie(Allergan)
• HAL Allergy Group
• Allergy Therapeutics
• Teva Pharmaceutical
• Viatris
• GlaxoSmithKline
• Stallergenes Greer